NovMetaPharma Market Cap

NovMetaPharma has a market cap or net worth of 118.01 billion as of April 29, 2026. Its market cap has increased by 1.11% in one year.

Market Cap

118.01B

Enterprise Value

n/a

Revenue

1.30B

Ranking

n/a

PE Ratio

76.58

Stock Price

9,190.00

Market Cap Chart

Since April 5, 2017, NovMetaPharma's market cap has increased from 74.59B to 118.01B, an increase of 58.21%. That is a compound annual growth rate of 5.19%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	118.01B	-27.91%
Dec 30, 2025	163.69B	187.16%
Dec 30, 2024	57.00B	-46.33%
Dec 29, 2022	106.21B	-45.89%
Dec 30, 2021	196.29B	-9.50%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BIO-FD&C	126.00B
Cell Biotech	111.01B
KoBioLabs	106.22B
CHA Vaccine Research Institute	103.70B
CORESTEMCHEMON	141.73B
TegoScience	101.36B
SunBio,Inc.	98.77B
Choong Ang Vaccine Laboratory	92.79B

Market Cap Rankings